Düsseldorf (ots) - The rating agency Moody's changed the outlook
for the rating of Gerresheimer from stable to positive and affirmed
the Ba2 rating.

Moody's gave as a reason for the positive change the company's
good operating performance. At the same time Moody's referred to the
strength and stability of the group's business model.

About Gerresheimer

Gerresheimer is an internationally leading manufacturer of high-
quality specialty products made of glass and plastic for the global
pharma & healthcare industry. Our wide product spectrum ranges from
pharmaceutical vials to complex drug delivery systems, such as
syringe systems, insulin pens and inhalers, for safe dosage and
application. Together with our partners we develop solutions which
set standards and have role-model status throughout their respective
business sectors.

Our Group of companies achieves in Europe, North and South America
and Asia sales of about E1 billion and employs around 9,400 people.
Through top-class technologies, convincing innovations and targeted
investments we are systematically expanding our strong market
position.

Originaltext: Gerresheimer AG
digital press kits: http://www.presseportal.de/pm/9072
press kits via RSS: http://www.presseportal.de/rss/pm_9072.rss2
ISIN: DE000A0LD6E6

Contact:
Burkhard Lingenberg
Director Corporate Communication & Marketing
Phone +49 211 6181-250
Fax +49 211 6181-241
E-mail Diese E-Mail-Adresse ist gegen Spam Bots geschützt, Sie müssen JavaScript aktivieren, damit Sie es sehen können

Investor Relations Contact
Anke Linnartz
Director Investor Relations
Phone +49 211 6181-314
Fax +49 211 6181-121
E-mail Diese E-Mail-Adresse ist gegen Spam Bots geschützt, Sie müssen JavaScript aktivieren, damit Sie es sehen können